Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
about
Lupus nephritis: the evolving role of novel therapeuticsCombined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAMA clinico-pathological study of lupus nephritis based on the International Society of Nephrology-Renal Pathology Society 2003 classification system.Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue.IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cellsThe emerging role of the inflammasome in kidney diseasesMathematical model of renal interstitial fibrosis.Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.A dexamethasone prodrug reduces the renal macrophage response and provides enhanced resolution of established murine lupus nephritis.Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study.Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritisDeficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.CD11b is protective in complement-mediated immune complex glomerulonephritis.Biomarkers for kidney involvement in pediatric lupus.Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritisDifferential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma.Relation of peritubular capillary features to class of lupus nephritisThe Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus NephritisCharacterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-respondersThe Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic LesionsInhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritisValidation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus.Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies.Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-TNF-like weak inducer of apoptosis (anti-TWEAK) monoclonal antibody.Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 yearsBiomarkers and updates on pediatrics lupus nephritis.Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis: A Large Multicenter Cross-Sectional Study.Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy.Role of TWEAK in lupus nephritis: a bench-to-bedside review.Overview of lupus nephritis management guidelines and perspective from Asia.Overview of lupus nephritis management guidelines and perspective from Asia.Proteomics and autoimmune kidney disease.Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.Renal involvement in primary Sjögren syndrome.Sustained remission in lupus nephritis: still a hard road ahead.Lupus nephritis and B-cell targeting therapy.Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis.
P2860
Q26998390-3318A2B0-A7E9-43EB-9CA0-1EFF2EE31C82Q33847584-EE927590-2CEB-48DE-8E86-1991A8F971DEQ33868909-14965C78-8673-4C7B-AD2B-01F08C456D6CQ34030907-98EC7E2B-60D3-407E-A902-756DD8CA69D4Q34053939-E291ED3E-0D69-46F0-9C78-9818A27A9318Q34307043-064E4BDF-EC1E-4E9B-8665-9DCF3F737DD6Q34314334-70A291ED-A5DD-4EB5-B505-B1B1A41F4D98Q35027749-86F559F4-7CA9-4241-A17E-34AFF10EF761Q35060548-E876C2B0-B8E9-427F-BEF8-4F4EF0F57C01Q35170232-EC46681D-CC5D-4AC1-8E91-E61CAD1C89F0Q35324023-8F6C3778-754C-4866-916A-AED2D4B6FCA4Q35550587-C2512861-513F-4D5A-9BCE-16C10C997630Q35584845-9551FC25-2BDC-4D7E-AF30-54150D0B6057Q35810911-1C941495-A1D3-4227-861E-38A29FA4AFDFQ36012345-704F7735-C80F-4DFB-8384-010FC0EA1557Q36083938-D6353596-B146-45FD-8A50-A1C75C756470Q36132720-22268DE1-0057-4AA0-9426-7158AC93A85BQ36187823-AB685A7E-B95C-4F98-B911-0D2E10DF3D6CQ36299959-D5E79E83-5C95-4162-B0DB-3D821BC8C989Q36302345-C67232D5-B33A-40DD-AE28-B978D5B58811Q36314988-A5E7F6A3-591B-404E-B5C0-493A6A98F46BQ36354235-DD15BD8A-3C44-4614-A749-66233BE1F09CQ36484106-0582B92D-4FEC-4700-8E54-4F5E200849BAQ36770851-646E2470-A412-4C23-ACDA-314B2A13AADBQ36806477-7939DFE2-F164-4FC6-8835-CE94B5034F87Q36844749-57A78676-A21B-4EF6-884E-1FDB65E618B2Q37030693-BDE27A38-C32E-4DF5-9DF3-B53C78C200DAQ37115262-2E96785E-01ED-4734-BC81-AD662DC69BADQ37167062-2EF2D9B2-838F-472E-9539-4CEAD776B84EQ37204946-8FCBF915-5F8C-4C32-96AD-48D72F1DBE81Q37464204-C9985210-5710-4A96-8A62-E4F767683E59Q38021183-C947F755-DD93-46BE-840D-B0EC2A3109FAQ38123242-0A8B07A3-E572-4AA1-84A2-D13E51CC54C6Q38175076-B038A23D-4A33-4B3E-AE4E-CF6748E98590Q38483988-94C77B9B-D218-4F4B-86E6-BEC5AC07D076Q38575862-1A5B3D96-928F-440D-B9D3-9A41EEBE40D8Q38633492-4A061269-F57B-4FAC-B246-E8B66CEFCEBEQ38641358-D8B58A71-8319-4B4C-99B9-F039928F3762Q38643755-03F2475B-FD27-4AE0-9037-B48B5030B704Q38806359-C6164B70-A838-4428-ABBA-166E486C886C
P2860
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
@ast
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
@en
type
label
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
@ast
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
@en
prefLabel
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
@ast
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
@en
P2093
P2860
P356
P1476
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
@en
P2093
Anthony Chang
Christine Hsieh
Daniel Brandt
Marcus R Clark
Riteesha Guttikonda
Tammy O Utset
P2860
P304
P356
10.1002/ACR.20441
P577
2011-06-01T00:00:00Z